| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2021-04-01 12:32 Tx date 2021-01-11 |
$LEXX
Lexaria Bioscience Corp. |
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
+273,543 vol |
7,399,847 | |
| Filed 2021-01-12 17:33 Tx date 2021-01-11 |
$LEXX
Lexaria Bioscience Corp. |
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
+273,543 vol |
||
| Filed 2021-02-03 17:43 Tx date 2021-01-11 |
$LEXX
Lexaria Bioscience Corp. |
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: CAB Financial Services Ltd. (Indirect Ownership)
|
Warrants
37 - Stock split or consolidation
|
$70,003
+6,667 vol $10.50 each |
206,667 | |
| Filed 2021-01-12 17:38 Tx date 2021-01-11 |
$LEXX
Lexaria Bioscience Corp. |
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
$70,003
+6,667 vol $10.50 each |
||
| Filed 2021-01-12 17:38 Tx date 2021-01-11 |
$LXRP
Lexaria Bioscience Corp. |
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
$70,003
+6,667 vol $10.50 each |
6,667 | |
| Filed 2021-01-12 17:36 Tx date 2021-01-11 |
$LXRP
Lexaria Bioscience Corp. |
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
$237,996
+23,333 vol $10.20 each |
723,333 | |
| Filed 2021-01-12 17:34 Tx date 2021-01-11 |
$LXRP
Lexaria Bioscience Corp. |
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: CAB Financial Services Ltd. (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
+215,912 vol |
6,693,256 | |
| Filed 2021-01-12 17:33 Tx date 2021-01-11 |
$LXRP
Lexaria Bioscience Corp. |
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
+273,543 vol |
7,399,847 | |
| Filed 2020-11-10 16:16 Tx date 2020-11-10 |
$LXRP
Lexaria Bioscience Corp. |
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: CAB Financial Services Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,799
+25,500 vol $0.1882 each |
6,477,344 | |
| Filed 2020-11-10 16:15 Tx date 2020-11-10 |
$LXRP
Lexaria Bioscience Corp. |
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: CAB Financial Services Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,199
+6,000 vol $0.1999 each |
6,451,844 | |
| Filed 2020-11-10 16:14 Tx date 2020-11-10 |
$LXRP
Lexaria Bioscience Corp. |
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: CAB Financial Services Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,950
+10,000 vol $0.195 each |
6,445,844 | |
| Filed 2020-11-10 16:14 Tx date 2020-11-09 |
$LXRP
Lexaria Bioscience Corp. |
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: CAB Financial Services Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,391
+22,000 vol $0.1996 each |
6,435,844 | |
| Filed 2020-11-10 16:13 Tx date 2020-11-09 |
$LXRP
Lexaria Bioscience Corp. |
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: CAB Financial Services Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,306
+6,500 vol $0.201 each |
6,413,844 | |
| Filed 2020-11-10 16:13 Tx date 2020-11-09 |
$LXRP
Lexaria Bioscience Corp. |
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: CAB Financial Services Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,600
+8,000 vol $0.20 each |
6,407,344 | |
| Filed 2020-11-10 16:12 Tx date 2020-11-09 |
$LXRP
Lexaria Bioscience Corp. |
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: CAB Financial Services Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,129
+10,000 vol $0.2129 each |
6,399,344 | |
| Filed 2020-11-10 16:12 Tx date 2020-11-09 |
$LXRP
Lexaria Bioscience Corp. |
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: CAB Financial Services Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,025
+10,000 vol $0.2025 each |
6,389,344 | |
| Filed 2020-11-10 16:11 Tx date 2020-11-09 |
$LXRP
Lexaria Bioscience Corp. |
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: CAB Financial Services Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,062
+37,500 vol $0.215 each |
6,379,344 | |
| Filed 2020-11-10 16:08 Tx date 2020-11-06 |
$LXRP
Lexaria Bioscience Corp. |
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: CAB Financial Services Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,306
+60,000 vol $0.2051 each |
6,341,844 | |
| Filed 2020-05-11 11:06 Tx date 2020-05-06 |
$LXRP
Lexaria Bioscience Corp. |
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: CAB Financial Services Ltd. (Indirect Ownership)
|
Warrants
11 - Acquisition or disposition carried out privately
|
$98,000
+200,000 vol $0.49 each |
200,000 | |
| Filed 2020-05-11 11:05 Tx date 2020-05-06 |
$LXRP
Lexaria Bioscience Corp. |
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: CAB Financial Services Ltd. (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$64,000
+200,000 vol $0.32 each |
6,281,844 |